{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:45:54Z","timestamp":1791409554828,"version":"4.3.3"},"reference-count":140,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2011,6,22]],"date-time":"2011-06-22T00:00:00Z","timestamp":1308700800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1007\/s00702-011-0676-8","type":"journal-article","created":{"date-parts":[[2011,6,21]],"date-time":"2011-06-21T07:09:34Z","timestamp":1308640174000},"page":"261-274","source":"Crossref","is-referenced-by-count":45,"title":["Involvement of kynurenines in Huntington\u2019s disease and stroke-induced brain damage"],"prefix":"10.1007","volume":"119","author":[{"given":"Trevor W.","family":"Stone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline M.","family":"Forrest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Stoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Gail","family":"Darlington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,6,22]]},"reference":[{"key":"676_CR1","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1080\/09629350120102370","volume":"10","author":"A Amann","year":"2001","unstructured":"Amann A, Widner B, Rieder J, Antretter H, Hoffmann G, Mayr V, Strohmenger HU, Fuchs D (2001) Monitoring of immune activation using biochemical changes in a porcine model of cardiac arrest. Mediat Inflamm 10:343\u2013346","journal-title":"Mediat Inflamm"},{"key":"676_CR2","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/0031-6989(87)90014-2","volume":"19","author":"L Bacciottini","year":"1987","unstructured":"Bacciottini L, Pellegrini-Giampietro DE, Bongianno F, Deluca G, Beni M, Politi V, Moroni F (1987) Biochemical and behavioral-studies on indole-pyruvic acid\u2014a keto-analogue of tryptophan. Pharmacol Res Commun 19:803\u2013817","journal-title":"Pharmacol Res Commun"},{"key":"676_CR3","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/S0024-3205(01)01215-2","volume":"69","author":"H Baran","year":"2001","unstructured":"Baran H, Kepplinger B, Herrera-Marschitz M, Stolze K, Lubec G, Nohl H (2001) Increased kynurenic acid in the brain after neonatal asphyxia. Life Sci 69:1249\u20131256","journal-title":"Life Sci"},{"key":"676_CR4","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.cnr.2006.09.010","volume":"6","author":"FC Barone","year":"2006","unstructured":"Barone FC, Kilgore KS (2006) Role of inflammation and cellular stress in brain injury and central nervous system diseases. Clin Neurosci Res 6:329\u2013356","journal-title":"Clin Neurosci Res"},{"key":"676_CR5","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1016\/S0140-6736(03)13304-1","volume":"361","author":"G Bates","year":"2003","unstructured":"Bates G (2003) Huntingtin aggregation and toxicity in Huntington\u2019s disease. Lancet 361:1642\u20131644","journal-title":"Lancet"},{"key":"676_CR6","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1432-2277.2004.00031.x","volume":"18","author":"TM Bauer","year":"2005","unstructured":"Bauer TM, Jiga LP, Chuang JJ, Randazzo M, Opelz G, Terness P (2005) Studying the immunosuppressive role of indoleamine 2, 3-dioxygenase: tryptophan metabolites suppress rat allogeneic T-cell responses in vitro and in vivo. Transpl Intern 18:95\u2013100","journal-title":"Transpl Intern"},{"key":"676_CR7","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/0022-510X(92)90191-M","volume":"108","author":"MF Beal","year":"1992","unstructured":"Beal MF, Matson WR, Storey E, Milbury P, Ryan EA, Ogawa T, Bird ED (1992) Kynurenic acid concentrations are reduced in Huntington\u2019s disease. J Neurol Sci 108:80\u201387","journal-title":"J Neurol Sci"},{"key":"676_CR8","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/321168a0","volume":"321","author":"MF Beal","year":"1986","unstructured":"Beal MF, Kowall NW, Ellison DW, Mazurek MF, Swartz KJ, Martin JB (1986) Replication of the neurochemical characteristics of Huntington\u2019s disease by quinolinic acid. Nature 321:168\u2013171","journal-title":"Nature"},{"key":"676_CR9","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1523\/JNEUROSCI.11-01-00147.1991","volume":"11","author":"MF Beal","year":"1991","unstructured":"Beal MF, Swartz KJ, Finn SF, Mazurek MF, Kowall NW (1991a) Neurochemical characterization of excitotoxin lesions in the cerebral cortex. J Neurosci 11:147\u2013158","journal-title":"J Neurosci"},{"key":"676_CR10","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1523\/JNEUROSCI.11-06-01649.1991","volume":"11","author":"MF Beal","year":"1991","unstructured":"Beal MF, Ferrante RJ, Swartz KJ, Kowall NW (1991b) Chronic quinolinic acid lesions in rats closely resemble Huntington\u2019s disease. J Neurosci 11:1649\u20131659","journal-title":"J Neurosci"},{"key":"676_CR11","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1038\/sj.bjp.0703250","volume":"129","author":"WMH Behan","year":"2000","unstructured":"Behan WMH, Stone TW (2000) Role of kynurenines in the neurotoxic actions of kainic acid. Br J Pharmacol 129:1764\u20131770","journal-title":"Br J Pharmacol"},{"key":"676_CR12","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1084\/jem.20080178","volume":"205","author":"M Bjorkqvist","year":"2008","unstructured":"Bjorkqvist M, Wild EJ, Thiele J, Silvestroni A, Andre R, Lahiri N et al (2008) A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington\u2019s disease. J Exp Med 205:1869\u20131877","journal-title":"J Exp Med"},{"key":"676_CR13","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nrn2038","volume":"8","author":"ML Block","year":"2007","unstructured":"Block ML, Zecca L, Hong JS (2007) Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci 8:57\u201369","journal-title":"Nat Rev Neurosci"},{"key":"676_CR14","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.pneurobio.2005.06.004","volume":"76","author":"ML Block","year":"2005","unstructured":"Block ML, Hong JS (2005) Microglia and inflammation-mediated neurodegenration: multiple triggers with a common mechanism. Prog Neurobiol 76:77\u201398","journal-title":"Prog Neurobiol"},{"key":"676_CR15","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/s11064-010-0187-2","volume":"35","author":"R Brouns","year":"2010","unstructured":"Brouns R, Verkerk R, Aerts T, De Surgeloose D, Wauters A, Scharpe S, De Deyn PP (2010) The role of tryptophan catabolism along the kynurenine pathway in acute ischemic stroke. Neurochem Res 35:1315\u20131322","journal-title":"Neurochem Res"},{"key":"676_CR16","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1750-3639.1999.tb00216.x","volume":"9","author":"SE Browne","year":"1999","unstructured":"Browne SE, Ferrante RJ, Beal MF (1999) Oxidative stress in Huntington\u2019s disease. Brain Pathol 9:147\u2013163","journal-title":"Brain Pathol"},{"key":"676_CR17","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/0306-4522(94)00431-4","volume":"64","author":"LH Burns","year":"1995","unstructured":"Burns LH, Pakzaban P, Deacon TW, Brownell AL, Tatter SB, Jenkins BG, Isacson O (1995) Selective putaminal excitotoxic lesions in nonhuman-primates model the movement disorder of Huntington disease. Neuroscience 64:1007\u20131017","journal-title":"Neuroscience"},{"key":"676_CR18","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0306-4522(94)90227-5","volume":"61","author":"R Carpenedo","year":"1994","unstructured":"Carpenedo R, Chiarugi A, Russi P, Lombardi G, Carla V, Pellicciari R, Moroni F, Mattoli L (1994) Inhibitors of kynurenine hydroxylase and kynureninase increase cerebral formation of kynurenate and have sedative and anticonvulsant activities. Neuroscience 61:237\u2013244","journal-title":"Neuroscience"},{"key":"676_CR19","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1523\/JNEUROSCI.19-08-03248.1999","volume":"19","author":"RJ Carter","year":"1999","unstructured":"Carter RJ, Lione LA, Humby T, Mangiarini L, Mahal A, Bates GP et al (1999) Characterization of progressive motor deficits in mice transgenic for the human Huntington\u2019s disease mutation. J Neurosci 19:3248\u20133257","journal-title":"J Neurosci"},{"key":"676_CR20","doi-asserted-by":"crossref","first-page":"5249","DOI":"10.1128\/IAI.73.8.5249-5251.2005","volume":"73","author":"CJ Clark","year":"2005","unstructured":"Clark CJ, Mackay GM, Smythe GA, Bustamante S, Stone TW, Phillips RS (2005) Prolonged survival of a murine model of cerebral malaria by kynurenine pathway inhibition. Infect Immun 73:5249\u20135251","journal-title":"Infect Immun"},{"key":"676_CR21","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0306-3623(92)90017-E","volume":"23","author":"JH Connick","year":"1992","unstructured":"Connick JH, Heywood GC, Sills GJ, Thompson GG, Brodie MJ, Stone TW (1992) Nicotinylalanine increases cerebral kynurenic acid content and has anticonvulsant activity. Gen Pharmacol 23:235\u2013239","journal-title":"Gen Pharmacol"},{"key":"676_CR22","doi-asserted-by":"crossref","first-page":"12725","DOI":"10.1523\/JNEUROSCI.4619-08.2008","volume":"28","author":"CM Cowan","year":"2008","unstructured":"Cowan CM, Fan MMY, Fan J, Shehadeh J, Zhang LYJ, Graham RK et al (2008) Polyglutamine-modulated striatal calpain activity in YAC transgenic huntington disease mouse model: impact on NMDA receptor function and toxicity. J Neurosci 28:12725\u201312735","journal-title":"J Neurosci"},{"key":"676_CR23","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/00004647-199907000-00007","volume":"19","author":"R Cozzi","year":"1999","unstructured":"Cozzi R, Carpenedo R, Moroni F (1999) Kynurenine hydroxylase inhibitors reduce ischaemic brain damage: studies with (m-nitrobenzoyl)alanine and 3, 4-dimethoxy-[N-4-(nitrophenyl)thiazol-2-yl]-benzenesulfonamide (Ro 61-8048) in models of focal or global ischaemia. J Cereb Blood Flow Metab 19:771\u2013777","journal-title":"J Cereb Blood Flow Metab"},{"key":"676_CR24","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1111\/j.1460-9568.2007.05838.x","volume":"26","author":"LG Darlington","year":"2007","unstructured":"Darlington LG, Mackay GM, Forrest CM, Stoy N, George C, Stone TW (2007) Altered kynurenine metabolism correlates with infarct volume in stroke. Eur J Neurosci 26:2211\u20132221","journal-title":"Eur J Neurosci"},{"key":"676_CR200","doi-asserted-by":"crossref","unstructured":"Darlington LG, Forrest CM, Mackay GM, Stoy N, Smith RA, Smith AJ, Stone TW (2010) On the biological significance of the 3-hydroxyanthranilic acid:anthranilic acid ratio. Int J Tryptophan Res 3:51\u201359","DOI":"10.4137\/IJTR.S4282"},{"key":"676_CR25","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0006-2952(87)90691-5","volume":"36","author":"JA Dykens","year":"1987","unstructured":"Dykens JA, Sullivan SG, Stern A (1987) Oxidative reactivity of the tryptophan metabolites 3-hydroxyanthranilate, quinolinate and picolinate. Biochem Pharmacol 36:211\u2013217","journal-title":"Biochem Pharmacol"},{"key":"676_CR26","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0006-8993(89)90216-3","volume":"495","author":"CL Eastman","year":"1989","unstructured":"Eastman CL, Guilarte TR (1989) Cytotoxicity of 3-hydroxykynurenine in a neuronal hybrid cell line. Brain Res 495:225\u2013231","journal-title":"Brain Res"},{"key":"676_CR27","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1007\/BF01101711","volume":"15","author":"CL Eastman","year":"1990","unstructured":"Eastman CL, Guilarte TR (1990) The role of hydrogen peroxide in the in vitro cytotoxicity of 3-hydroxykynurenine. Neurochem Res 15:1101\u20131107","journal-title":"Neurochem Res"},{"key":"676_CR28","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/00001756-199701200-00011","volume":"8","author":"MG Espey","year":"1997","unstructured":"Espey MG, Chernyshev ON, Reinhard JF, Namboodiri MAA, Colton CA (1997) Activated human microglia produce the excitotoxin quinolinic acid. Neuroreport 8:431\u2013434","journal-title":"Neuroreport"},{"key":"676_CR29","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/jlb.57.2.199","volume":"57","author":"MG Espey","year":"1995","unstructured":"Espey MG, Moffett JR, Namboodiri MAA (1995) Temporal and spatial changes of quinolinic acid immunoreactivity in the immune-system of lipopolysaccharide-stimulated mice. J Leukocyte Biol 57:199\u2013206","journal-title":"J Leukocyte Biol"},{"key":"676_CR30","doi-asserted-by":"crossref","unstructured":"Fainardi E, Rizzo R, Melchiorri L, Castellazzi M, Paolino E, Tola MR, Granieri E, Baricordi OR (2006) Intrathecal synthesis of soluble HLA-G and HLA-I molecules are reciprocally associated to clinical and MRI activity in patients with multiple sclerosis. Mult Scler 12:2\u201312","DOI":"10.1191\/1352458506ms1241oa"},{"key":"676_CR31","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1182\/blood-2006-11-057125","volume":"110","author":"U Feger","year":"2007","unstructured":"Feger U, Tolosa E, Huang Y-H, Waschbisch A, Biedermann T, Melms A, Wiendl H (2007) HLA-G expression defines a novel regulatory T-cell subset present in human peripheral blood and sites of inflammation. Blood 110:568\u2013577","journal-title":"Blood"},{"key":"676_CR32","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1080\/10715760400011437","volume":"38","author":"CM Forrest","year":"2004","unstructured":"Forrest CM, Mackay GM, Stoy N, Egerton M, Christofides J, Stone TW, Darlington LG (2004) Tryptophan loading induces oxidative stress. Free Radic Res 38:1167\u20131171","journal-title":"Free Radic Res"},{"key":"676_CR33","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1471-4159.2009.06442.x","volume":"112","author":"CM Forrest","year":"2010","unstructured":"Forrest CM, Mackay GM, Stoy N, Spiden SL, Taylor R, Stone TW, Darlington LG (2010) Blood levels of kynurenines, interleukin IL-23 and sHLA-G at different stages of Huntington\u2019s disease. J Neurochem 112:112\u2013122","journal-title":"J Neurochem"},{"key":"676_CR34","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1111\/j.1440-1681.2006.04490.x","volume":"33","author":"CM Forrest","year":"2006","unstructured":"Forrest CM, Mackay GM, Oxford L, Stoy N, Stone TW, Darlington LG (2006) Kynurenine pathway metabolism in patients with osteoporosis after two years of drug treatment. Clin Exp Pharmacol Physiol 33:1078\u20131087","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"676_CR35","first-page":"873","volume":"3","author":"D Fuchs","year":"1990","unstructured":"Fuchs D, Moeller A-A, Reibnegger G, Stoeckle E, Werner E-R, Wachter H (1990) Decreased serum tryptophan in patients with HIV-1 infection correlates with increased serum neopterin and with neurologic\/psychiatric symptoms. J Acquir Immune Defic Syndr 3:873\u2013876","journal-title":"J Acquir Immune Defic Syndr"},{"key":"676_CR36","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/gepi.20317","volume":"32","author":"J Gay\u00e1n","year":"2008","unstructured":"Gay\u00e1n J, Brocklebank D, Andresen JM, Alkorta-Aranburu G, US-Venezuela Collaborative Research Group, Zameel Cader M, Roberts SA, Cherny SS, Wexler NS, Cardon LR, Housman DE (2008) Genomewide linkage scan reveals novel loci modifying age of onset of Huntington\u2019s disease in the Venezuelan HD kindreds. Genet Epidemiol 32:445\u2013453","journal-title":"Genet Epidemiol"},{"key":"676_CR37","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1365-2990.1995.tb01062.x","volume":"21","author":"J Gehrmann","year":"1995","unstructured":"Gehrmann J, Banati RB, Wiessnert C, Hossmann KA, Kreutzberg GW (1995) Reactive microglia in cerebral ischemia\u2014an early mediator of tissue damage. Neuropathol Appl Neurobiol 21:277\u2013289","journal-title":"Neuropathol Appl Neurobiol"},{"key":"676_CR38","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S0006-291X(02)02917-0","volume":"300","author":"GI Giles","year":"2003","unstructured":"Giles GI, Collins CA, Stone TW, Jacob C (2003) Electrochemical and in vitro evaluation of the redox properties of kynurenine species. Biochem Biophys Res Commun 300:719\u2013724","journal-title":"Biochem Biophys Res Commun"},{"key":"676_CR39","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/ng1542","volume":"37","author":"F Giorgini","year":"2005","unstructured":"Giorgini F, Guidetti P, Nguyen QV, Bennett SC, Muchowski PJ (2005) A genomic screen in yeast implicates kynurenine 3-monooxygenase as a therapeutic target for Huntington disease. Nat Genet 37:526\u2013531","journal-title":"Nat Genet"},{"key":"676_CR40","doi-asserted-by":"crossref","first-page":"7390","DOI":"10.1074\/jbc.M708192200","volume":"283","author":"F Giorgini","year":"2008","unstructured":"Giorgini F, Moller T, Kwan W, Zwilling D, Wacker JL, Hong S, Tsai LC-L, Cheah CS, Schwarcz R, Guidetti P, Muchowski PJ (2008) Histone deacetylase inhibition modulates kynurenine pathway activation in yeast, microglia and mice expressing a mutant huntingtin fragment. J Biol Chem 283:7390\u20137400","journal-title":"J Biol Chem"},{"key":"676_CR41","doi-asserted-by":"crossref","first-page":"7266","DOI":"10.1021\/bi992997s","volume":"39","author":"LE Goldstein","year":"2000","unstructured":"Goldstein LE, Leopold MC, Huang X et al (2000) 3-Hydroxykynurenine and 3-hydroxy-anthranilic acid generate hydrogen peroxide and promote \u03b1-crystallin cross-linking by metal ion reduction. Biochemistry 39:7266\u20137275","journal-title":"Biochemistry"},{"key":"676_CR42","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1095\/biolreprod.105.040089","volume":"73","author":"A Gonzalez-Hernandez","year":"2005","unstructured":"Gonzalez-Hernandez A, LeMaoult J, Lopez A, Alegre E, Caumartin J, Le Rond S et al (2005) Linking two immuno-suppressive molecules: indoleamine 2, 3 dioxygenase can modify HLA-G cell-surface expression. Biol Reprod 73:571\u2013578","journal-title":"Biol Reprod"},{"key":"676_CR43","doi-asserted-by":"crossref","first-page":"3857","DOI":"10.1046\/j.1460-9568.1999.00806.x","volume":"11","author":"P Guidetti","year":"1999","unstructured":"Guidetti P, Schwarcz R (1999) 3-Hydroxykynurenine potentiates quinolinate but not NMDA toxicity in the rat striatum. Eur J Neurosci 11:3857\u20133863","journal-title":"Eur J Neurosci"},{"key":"676_CR44","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0304-3940(00)00956-3","volume":"283","author":"P Guidetti","year":"2000","unstructured":"Guidetti P, Reddy PH, Tagle DA, Schwarcz R (2000) Early kynureninergic impairment in Huntington\u2019s disease and in a transgenic animal model. Neurosci Lett 283:233\u2013235","journal-title":"Neurosci Lett"},{"key":"676_CR45","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.nbd.2004.07.006","volume":"17","author":"P Guidetti","year":"2004","unstructured":"Guidetti P, Luthi-Carter RE, Augood SJ, Schwarcz R (2004) Neostriatal and cortical quinolinate levels are increased in early grade Huntington\u2019s disease. Neurobiol Dis 17:455\u2013461","journal-title":"Neurobiol Dis"},{"key":"676_CR46","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.nbd.2006.02.011","volume":"23","author":"P Guidetti","year":"2006","unstructured":"Guidetti P, Bates GP, Graham RK, Hayden MR, Leavitt BR, MacDonald ME, Slow EJ, Wheeler VC, Woodman B, Schwarcz R (2006) Elevated brain 3-hydroxykynurenine and quinolinate in Huntington disease mice. Neurobiol Dis 23:190\u2013197","journal-title":"Neurobiol Dis"},{"key":"676_CR47","doi-asserted-by":"crossref","first-page":"12884","DOI":"10.1523\/JNEUROSCI.4101-07.2007","volume":"27","author":"GJ Guillemin","year":"2007","unstructured":"Guillemin GJ, Cullen KM, Lim CK, Smythe GA, Garner B, Kapoor V, Takikawa O, Brew BJ (2007) Characterization of the kynurenine pathway in human neurons. J Neurosci 27:12884\u201312892","journal-title":"J Neurosci"},{"key":"676_CR48","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrm2101","volume":"8","author":"C Haass","year":"2007","unstructured":"Haass C, Selkoe DJ (2007) Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer\u2019s amyloid beta-peptide. Nat Rev Mol Cell Biol 8:101\u2013112","journal-title":"Nat Rev Mol Cell Biol"},{"key":"676_CR49","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/sj.bjp.0701834","volume":"124","author":"CA Harris","year":"1998","unstructured":"Harris CA, Miranda AF, Tanguay JJ, Boegman RJ, Beninger RJ, Jhamandas K (1998) Modulation of striatal quinolinate neurotoxicity by elevation of endogenous brain kynurenic acid. Br J Pharmacol 124:391\u2013399","journal-title":"Br J Pharmacol"},{"key":"676_CR50","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/s11064-007-9463-1","volume":"33","author":"B Hassel","year":"2008","unstructured":"Hassel B, Tessler S, Faull RLM, Emson PC (2008) Glutamate uptake is reduced in prefrontal cortex in Huntington\u2019s disease. Neurochem Res 33:232\u2013237","journal-title":"Neurochem Res"},{"key":"676_CR51","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.1523\/JNEUROSCI.5599-08.2009","volume":"29","author":"MY Heng","year":"2009","unstructured":"Heng MY, Detloff PJ, Wang PL, Tsien JZ, Albin RL (2009) In vivo evidence for NMDA receptor-mediated excitotoxicity in a murine genetic model of Huntington disease. J Neurosci 29:3200\u20133205","journal-title":"J Neurosci"},{"key":"676_CR52","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1749-6632.1993.tb18300.x","volume":"679","author":"MP Heyes","year":"1993","unstructured":"Heyes MP (1993) Quinolinic acid and inflammation. Ann NY Acad Sci 679:211\u2013216","journal-title":"Ann NY Acad Sci"},{"key":"676_CR53","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1093\/brain\/115.5.1249","volume":"115","author":"MP Heyes","year":"1992","unstructured":"Heyes MP, Saito K, Crowley JS, Davis LE, Demitrack MA, Der M, Dilling LA, Elia J, Kruesi MJP, Lackner A, Larsen SA, Lee K, Leonard HL, Markey SP, Martin A, Milstein S, Mouradian MM, Pranzatelli MR, Quearry BJ, Salazar A, Smith M, Strauss SE, Sunderland T, Swedo SW, Tourtellotte WW (1992a) Quinolinic acid and kynurenine pathway metabolism in inflammatory and noninflammatory neurological disease. Brain 115:1249\u20131273","journal-title":"Brain"},{"key":"676_CR54","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1042\/bj2830633","volume":"283","author":"MP Heyes","year":"1992","unstructured":"Heyes MP, Saito K, Markey SP (1992b) Human macrophages convert l-tryptophan into the neurotoxin quinolinic acid. Biochem J 283:633\u2013635","journal-title":"Biochem J"},{"key":"676_CR55","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1042\/bj3200595","volume":"320","author":"MP Heyes","year":"1996","unstructured":"Heyes MP, Achim CL, Wiley CA, Major EO, Saito K, Markey SP (1996) Human microglia convert l-tryptophan into the neurotoxin quinolinic acid. Biochem J 320:595\u2013597","journal-title":"Biochem J"},{"key":"676_CR56","doi-asserted-by":"crossref","first-page":"7463","DOI":"10.1523\/JNEUROSCI.21-19-07463.2001","volume":"21","author":"C Hilmas","year":"2001","unstructured":"Hilmas C, Pereira EF, Alkondon M, Rassoulpour A, Schwarcz R (2001) The brain metabolites kynurenic acid inhibits \u03b17-nicotinic receptor activity and increases non-\u03b17 nicotinic receptor expression. J Neurosci 21:7463\u20137473","journal-title":"J Neurosci"},{"key":"676_CR57","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1515\/pteridines.2004.15.3.107","volume":"15","author":"G Hoffmann","year":"2004","unstructured":"Hoffmann G, Schobersberger W (2004) Neopterin: a mediator of the cellular immune system. Pteridines 15:107\u2013112","journal-title":"Pteridines"},{"key":"676_CR58","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0306-4522(94)00494-P","volume":"65","author":"Q Huang","year":"1995","unstructured":"Huang Q, Zhou D, Sapp E, Aizawa H, Ge P, Bird ED et al (1995) Quinolinic acid-induced increases in calbindin-d-28\u00a0k immunoreactivity in rat striatal neurons in-vivo and in-vitro mimic the pattern seen in Huntingtons-disease. Neuroscience 65:397\u2013407","journal-title":"Neuroscience"},{"key":"676_CR59","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.surneu.2005.12.028","volume":"66","author":"J Huang","year":"2006","unstructured":"Huang J, Uphadyay UM, Tamargo RJ (2006) Inflammation in stroke and focal cerebral ischemia. Surg Neurol 66:232\u2013245","journal-title":"Surg Neurol"},{"key":"676_CR60","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0306-4522(98)00724-6","volume":"92","author":"PE Hughes","year":"1999","unstructured":"Hughes PE, Alexi T, Williams CE, Clark RG, Gluckman PD (1999) Administration of recombinant human Activin-A has powerful neurotrophic effects on select striatal phenotypes in the quinolinic acid lesion model of Huntington\u2019s disease. Neuroscience 92:197\u2013209","journal-title":"Neuroscience"},{"key":"676_CR61","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.coph.2009.05.007","volume":"9","author":"JS Hunt","year":"2009","unstructured":"Hunt JS, Langat DL (2009) HLA-G: a human pregnancy modulator. Curr Opin Pharmacol 9:462\u2013469","journal-title":"Curr Opin Pharmacol"},{"key":"676_CR62","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0022-510X(94)00280-2","volume":"130","author":"D Jauch","year":"1995","unstructured":"Jauch D, Urbanska EM, Guidetti P, Bird ED, Vonsattel JP, Whetsell WO, Schwarcz R (1995) Dysfunction of brain kynurenic acid metabolism in Huntington\u2019s disease: focus on kynurenine aminotransferase. J Neurol Sci 130:39\u201347","journal-title":"J Neurol Sci"},{"key":"676_CR63","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/molehr\/7.2.195","volume":"7","author":"T Kanai","year":"2001","unstructured":"Kanai T, Fujii T, Kozuma S, Yamashita T, Miki A, Kikuchi A, Taketani Y (2001) Soluble HLA-G influences the release of cytokines from allogeneic peripheral blood mononuclear cells in culture. Mol Human Reprod 7:195\u2013200","journal-title":"Mol Human Reprod"},{"key":"676_CR64","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1159\/000086295","volume":"14","author":"B Kepplinger","year":"2005","unstructured":"Kepplinger B, Baran H, Kainz A, Ferraz-Leite H, Newcombe J, Kalina P (2005) Age-related increase of kynurenic acid in human cerebrospinal fluid-IgG and beta(2)-microglobulin changes. Neurosignals 14:126\u2013135","journal-title":"Neurosignals"},{"key":"676_CR65","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/1531-8249(199912)46:6<842::AID-ANA6>3.0.CO;2-O","volume":"46","author":"S Kuemmerle","year":"1999","unstructured":"Kuemmerle S, Gutekunst CA, Klein AM, Li XJ, Li SH, Beal MF, Hersch SM et al (1999) Huntingtin aggregates may not predict neuronal death in Huntington\u2019s disease. Ann Neurol 46:842\u2013849","journal-title":"Ann Neurol"},{"key":"676_CR66","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1365-2567.2005.02224.x","volume":"116","author":"S Le Rond","year":"2005","unstructured":"Le Rond S, Gonzalez A, Gonzalez ASL, Carosella ED, Rouas-Freiss N (2005) Indoleamine 2, 3 dioxygenase and human leucocyte antigen-G inhibit the T-cell alloproliferative response through two independent pathways. Immunology 116:297\u2013307","journal-title":"Immunology"},{"key":"676_CR67","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1515\/CCLM.1998.132","volume":"36","author":"F Leblhuber","year":"1998","unstructured":"Leblhuber F, Walli J, Jellinger K, Tilz GP, Widner B, Laccone F, Fuchs D (1998) Activated immune system in patients with Huntington\u2019s disease. Clin Chem Lab Med 36:747\u2013750","journal-title":"Clin Chem Lab Med"},{"key":"676_CR68","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.imlet.2010.05.008","volume":"132","author":"SM Lee","year":"2010","unstructured":"Lee SM, Lee YS, Choi JH, Park SG, Choi IW, Joo YD, Lee WS, Lee JN, Choi I, Seo K (2010) Tryptophan metabolite 3-hydroxyanthranilic acid selectively induces activated T cell death via intracellular GSH depletion. Immunol Lett 132:53\u201360","journal-title":"Immunol Lett"},{"key":"676_CR69","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.neuint.2006.04.017","volume":"50","author":"G Leipnitz","year":"2006","unstructured":"Leipnitz G, Schumacher C, Dalcin KB et al (2006) In vitro evidence for an antioxidant role of 3-hydroxykynurenine and 3-hydroxyanthranilic acid in the brain. Neurochem Int 50:83\u201394","journal-title":"Neurochem Int"},{"key":"676_CR70","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1016\/j.molimm.2006.01.007","volume":"43","author":"AS L\u00f3pez","year":"2006","unstructured":"L\u00f3pez AS, Alegre E, LeMaoult J, Carosella E, Gonz\u00e1lez A (2006) Regulatory role of tryptophan degradation pathway in HLA-G expression by human monocyte-derived dendritic cells. Mol Immunol 43:2151\u20132160","journal-title":"Mol Immunol"},{"key":"676_CR71","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.imlet.2008.01.001","volume":"117","author":"AS L\u00f3pez","year":"2008","unstructured":"L\u00f3pez AS, Alegre E, D\u00edaz-Lagares A, Garc\u00eda-Gir\u00f3n C, Coma MJ, Gonz\u00e1lez A (2008) Effect of 3-hydroxyanthranilic acid in the immunosuppressive molecules indoleamine dioxygenase and HLA-G in macrophages. Immunol Lett 117:91\u201395","journal-title":"Immunol Lett"},{"key":"676_CR72","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1468-1331.2006.01220.x","volume":"13","author":"GM Mackay","year":"2006","unstructured":"Mackay GM, Forrest CM, Stoy N, Christofides J, Egerton M, Stone TW, Darlington LG (2006) Tryptophan metabolism and oxidative stress in patients with chronic brain injury. Eur J Neurol 13:30\u201342","journal-title":"Eur J Neurol"},{"key":"676_CR73","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jns.2005.05.006","volume":"236","author":"L Marquardt","year":"2005","unstructured":"Marquardt L, Ruf A, Mansmann U, Winter R, Buggle F, Kallenberg K, Grau AJ (2005) Inflammatory response after acute stroke. J Neurol Sci 236:65\u201371","journal-title":"J Neurol Sci"},{"key":"676_CR74","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1136\/gut.2009.185108","volume":"59","author":"G Matteoli","year":"2010","unstructured":"Matteoli G, Mazzini E, Iliev ID, Mileti E, Fallarino F, Puccetti P, Chieppa M, Rescigno M (2010) Gut CD103+dendritic cells express indoleamine 2, 3-dioxygenase which influences T regulatory\/T effector cell balance and oral tolerance induction. Gut 59:595\u2013604","journal-title":"Gut"},{"key":"676_CR75","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.4049\/jimmunol.0903670","volume":"185","author":"JD Mezrich","year":"2010","unstructured":"Mezrich JD, Fechner JH, Zhang X, Johnson BP, Burlingham WJ, Bradfield CA (2010) An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells. J Immunol 185:3190\u20133198","journal-title":"J Immunol"},{"key":"676_CR76","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.neuroscience.2008.02.004","volume":"153","author":"BR Miller","year":"2008","unstructured":"Miller BR, Dorner JL, Shou M, Sari Y, Barton SJ, Sengelaub DR et al (2008) Up-regulation of GLT1 expression increases glutamate uptake and attenuates the Huntington\u2019s disease phenotype in the R6\/2 mouse. Neuroscience 153:329\u2013337","journal-title":"Neuroscience"},{"key":"676_CR77","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0014-2999(99)00196-X","volume":"375","author":"F Moroni","year":"1999","unstructured":"Moroni F (1999) Tryptophan metabolism and brain function: focus on kynurenine and other indole metabolites. Eur J Pharmacol 375:87\u2013100","journal-title":"Eur J Pharmacol"},{"key":"676_CR78","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1126\/science.281.5380.1191","volume":"281","author":"DH Munn","year":"1998","unstructured":"Munn DH, Zhou M, Attwood JT, Bondarev I, Conway SJ, Marshall B et al (1998) Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 281:1191\u20131193","journal-title":"Science"},{"key":"676_CR79","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1254\/jjp.71.183","volume":"71","author":"Y Nakagami","year":"1996","unstructured":"Nakagami Y, Saito H, Katsuki H (1996) 3-Hydroxykynurenine toxicity on the rat striatum in vivo. Jpn J Pharmacol 71:183\u2013186","journal-title":"Jpn J Pharmacol"},{"key":"676_CR80","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1248\/bpb.32.41","volume":"32","author":"K Narui","year":"2009","unstructured":"Narui K, Noguchi N, Saito A, Kakimi K, Motomura N, Kubo K (2009) Anti-infectious activity of tryptophan metabolites in the l-tryptophan\u2013l-kynurenine pathway. Biol Pharm Bull 32:41\u201344","journal-title":"Biol Pharm Bull"},{"key":"676_CR81","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2174\/1567202054368326","volume":"2","author":"H Nemeth","year":"2005","unstructured":"Nemeth H, Toldi J, Vecsei L (2005) Role of kynurenines in the central and peripheral nervous systems. Curr Neurovasc Res 2:249\u2013260","journal-title":"Curr Neurovasc Res"},{"key":"676_CR82","doi-asserted-by":"crossref","first-page":"12553","DOI":"10.1073\/pnas.93.22.12553","volume":"93","author":"S Okuda","year":"1996","unstructured":"Okuda S, Nishiyama N, Saito H, Katsuki H (1996) Hydrogen peroxide-mediated neuronal cell death induced by an endogenous neurotoxin, 3-hydroxykynurenine. Proc Natl Acad Sci USA 93:12553\u201312558","journal-title":"Proc Natl Acad Sci USA"},{"key":"676_CR83","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1046\/j.1471-4159.1998.70010299.x","volume":"70","author":"S Okuda","year":"1998","unstructured":"Okuda S, Nishiyama N, Saito H, Katsuki H (1998) 3-Hydroxykynurenine, an endogenous oxidative stress generator, causes neuronal cell death with apoptotic features and region selectivity. J Neurochem 70:299\u2013307","journal-title":"J Neurochem"},{"key":"676_CR84","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0304-3940(92)90749-W","volume":"144","author":"SJ Pearson","year":"1992","unstructured":"Pearson SJ, Reynolds GP (1992) Increased brain concentrations of a neurotoxin, 3-hydroxy-kynurenine, in Huntington\u2019s disease. Neurosci Lett 144:199\u2013201","journal-title":"Neurosci Lett"},{"key":"676_CR85","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/BF01276566","volume":"102","author":"SJ Pearson","year":"1995","unstructured":"Pearson SJ, Meldrum A, Reynolds GP (1995) An investigation of the activities of 3-hydroxykynureninease and kynurenine aminotransferase in the brain in Huntington\u2019s disease. J Neural Transm 102:67\u201373","journal-title":"J Neural Transm"},{"key":"676_CR86","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.bbr.2008.11.037","volume":"199","author":"V Perez-De La Cruz","year":"2009","unstructured":"Perez-De La Cruz V, Elinos-Calderon D, Robledo-Arratia Y, Medina-Campos ON, Pedraza-Chaverri J, Ali SF, Santamaria A (2009) Targeting oxidative\/nitrergic stress ameliorates motor impairment, and attenuates synaptic mitochondrial dysfunction and lipid peroxidation in two models of Huntington\u2019s disease. Behav Brain Res 199:210\u2013217","journal-title":"Behav Brain Res"},{"key":"676_CR87","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/0006-8993(82)91048-4","volume":"247","author":"MN Perkins","year":"1982","unstructured":"Perkins MN, Stone TW (1982) An iontophoretic investigation of the actions of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acid. Brain Res 247:184\u2013187","journal-title":"Brain Res"},{"key":"676_CR88","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.mad.2006.01.020","volume":"127","author":"M Pertovaara","year":"2006","unstructured":"Pertovaara M, Raitala A, Lehtimaki T, Karhunen PJ, Oja SS, Jylha M, Hervonen A, Hurme M (2006) Indoleamine 2,3-dioxygenase activity in nonagenarians is markedly increased and predicts mortality. Mech Ageing Develop 127:497\u2013499","journal-title":"Mech Ageing Develop"},{"key":"676_CR89","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/978-1-4615-4709-9_29","volume":"467","author":"V Politi","year":"1999","unstructured":"Politi V, Deluca G, Gallai V, Puca O, Comin M (1999) Clinical experiences with the use of indole-3-pyruvic acid. Adv Exp Med Biol 467:227\u2013232","journal-title":"Adv Exp Med Biol"},{"key":"676_CR90","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0361-9230(94)90109-0","volume":"35","author":"P Popoli","year":"1994","unstructured":"Popoli P, Pezzola A, Domenici ME, Sagratella S, Diana G, Caporali MG et al (1994) Behavioural and electrophysiological correlates of the quinolinic acid rat model of Huntington\u2019s disease in rats. Brain Res Bull 35:329\u2013335","journal-title":"Brain Res Bull"},{"key":"676_CR91","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S0140-6736(89)90987-2","volume":"2","author":"GP Reynolds","year":"1989","unstructured":"Reynolds GP, Pearson SJ (1989) Increased brain 3-hydroxykynurenine in Huntington\u2019s disease. Lancet 2:979\u2013980","journal-title":"Lancet"},{"key":"676_CR92","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1093\/brain\/awp074","volume":"132","author":"J Rodgers","year":"2009","unstructured":"Rodgers J, Stone TW, Barratt MP, Bradley B, Kennedy PG (2009) Kynurenine pathway inhibition reduces central nervous system inflammation in a model of human African trypanosomiasis. Brain 132:1259\u20131267","journal-title":"Brain"},{"key":"676_CR93","doi-asserted-by":"crossref","first-page":"4378","DOI":"10.1021\/jm970467t","volume":"40","author":"S Roever","year":"1997","unstructured":"Roever S, Cesura AM, Hugenin P, Kettler R, Szente A (1997) Synthesis and biochemical evaluation of N-(4-phenylthiazol-2-yl)benzenesulfonamides as high-affinity inhibitors of kynurenine 3-hydroxylase. J Med Chem 40:4378\u20134385","journal-title":"J Med Chem"},{"key":"676_CR94","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/WCO.0b013e328304b692","volume":"21","author":"E Roze","year":"2008","unstructured":"Roze E, Saudou F, Caboche J (2008) Pathophysiology of Huntington\u2019s disease: from huntingtin functions to potential treatments. Curr Opin Neurol 21:497\u2013503","journal-title":"Curr Opin Neurol"},{"key":"676_CR95","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0306-4522(92)90467-G","volume":"51","author":"K Saito","year":"1992","unstructured":"Saito K, Markey SP, Heyes MP (1992) Effects of immune activation on quinolinic acid and neuroactive kynurenines in the mouse. Neuroscience 51:25\u201339","journal-title":"Neuroscience"},{"key":"676_CR96","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1471-4159.1993.tb05836.x","volume":"60","author":"K Saito","year":"1993","unstructured":"Saito K, Nowak TS, Markey SP, Heyes MP (1993a) Mechanism of delayed increases in kynurenine pathway metabolism in damaged brain-regions following transient cerebral-ischemia. J Neurochem 60:180\u2013192","journal-title":"J Neurochem"},{"key":"676_CR97","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1111\/j.1471-4159.1993.tb07443.x","volume":"61","author":"K Saito","year":"1993","unstructured":"Saito K, Nowak TS, Suyama K, Quearry BJ, Saito M, Crowley JS, Markey SP, Heyes MP (1993b) Kynurenine pathway enzymes in brain\u2014responses to ischemic brain injury versus systemic immune activation. J Neurochem 61:2061\u20132070","journal-title":"J Neurochem"},{"key":"676_CR98","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/jnen\/60.2.161","volume":"60","author":"E Sapp","year":"2001","unstructured":"Sapp E, Kegel KB, Aronin N, Hashikawa T, Uchiyama Y, Tohyama K et al (2001) Early and progressive accumulation of reactive microglia in the Huntington disease brain. J Neuropathol Exp Neurol 60:161\u2013172","journal-title":"J Neuropathol Exp Neurol"},{"key":"676_CR99","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1098\/rstb.1999.0447","volume":"354","author":"K Sathasivam","year":"1999","unstructured":"Sathasivam K, Hobbs C, Mangiarini L, Mahal A, Turmaine M, Doherty P et al (1999) Transgenic models of Huntington\u2019s disease. Philos Trans R Soc B Biol Sci 354:963\u2013969","journal-title":"Philos Trans R Soc B Biol Sci"},{"key":"676_CR100","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1111\/j.1471-4159.2010.06675.x","volume":"113","author":"KV Sathyasaikumar","year":"2010","unstructured":"Sathyasaikumar KV, Stachowski EK, Amori L, Guidetti P, Muchowski PJ, Schwarcz R (2010) Dysfunctional kynurenine pathway metabolism in the R6\/2 mouse model of Huntington\u2019s disease. J Neurochem 113:1416\u20131425","journal-title":"J Neurochem"},{"key":"676_CR101","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1515\/pteridines.2004.15.3.75","volume":"15","author":"K Schroecksnadel","year":"2004","unstructured":"Schroecksnadel K, Murr C, Winkler C, Wirleitner B, Fruith LC, Fuchs D (2004) Neopterin to monitor clinical pathologies involving interferon-gamma production. Pteridines 15:75\u201390","journal-title":"Pteridines"},{"key":"676_CR102","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1126\/science.6849138","volume":"219","author":"R Schwarcz","year":"1983","unstructured":"Schwarcz R, Jnr Whetsell WO, Mangano RM (1983) Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain. Science 219:316\u2013318","journal-title":"Science"},{"key":"676_CR103","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.1073\/pnas.85.11.4079","volume":"85","author":"R Schwarcz","year":"1988","unstructured":"Schwarcz R, Okuno E, White RJ, Bird ED, Jnr Whetsell WO (1988) 3-Hydroxyanthranilate oxygenase activity is increased in the brains of Huntington disease victims. Proc Natl Acad Sci USA 85:4079\u20134081","journal-title":"Proc Natl Acad Sci USA"},{"key":"676_CR104","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/jpet.102.034439","volume":"303","author":"R Schwarcz","year":"2002","unstructured":"Schwarcz R, Pellicciari R (2002) Manipulation of brain kynurenines: glial targets, neuronal effects, and clinical opportunities. J Pharmacol Exp Ther 303:1\u201310","journal-title":"J Pharmacol Exp Ther"},{"key":"676_CR105","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.pneurobio.2009.04.005","volume":"90","author":"R Schwarcz","year":"2009","unstructured":"Schwarcz R, Guidetti P, Sathyasaikumar KV, Muchowski PJ (2009) Of mice, rats and men: revisiting the quinolinic acid hypothesis of Huntington\u2019s disease. Progr Neurobiol 90:230\u2013245","journal-title":"Progr Neurobiol"},{"key":"676_CR106","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/ana.410320309","volume":"32","author":"M Schwarz","year":"1992","unstructured":"Schwarz M, Block F, Topper R, Sontag KH, Noth J (1992) Abnormalities of somatosensory evoked-potentials in the quinolinic acid model of Huntingtons-disease\u2014evidence that basal ganglia modulate sensory cortical input. Ann Neurol 32:358\u2013364","journal-title":"Ann Neurol"},{"key":"676_CR107","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1515\/pteridines.2002.13.1.9","volume":"13","author":"B Sperner-Unterweger","year":"2002","unstructured":"Sperner-Unterweger B, Miller C, Holzner B, Laich A, Widner B, Fleischhacker WW, Fuchs D (2002) Immunologic alterations in schizophrenia: neopterin, L-kynurenine, tryptophan and T-cell subsets in the acute stage of illness. Pteridines 13:9\u201314","journal-title":"Pteridines"},{"key":"676_CR108","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0031-6997(25)00441-7","volume":"45","author":"TW Stone","year":"1993","unstructured":"Stone TW (1993) The neuropharmacology of quinolinic and kynurenic acids. Pharmacol Rev 45:309\u2013379","journal-title":"Pharmacol Rev"},{"key":"676_CR109","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nrd870","volume":"1","author":"TW Stone","year":"2002","unstructured":"Stone TW, Darlington LG (2002) Endogenous kynurenines as targets for drug discovery and development. Nat Rev Drug Discov 1:609\u2013620","journal-title":"Nat Rev Drug Discov"},{"key":"676_CR110","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0014-2999(81)90587-2","volume":"72","author":"TW Stone","year":"1981","unstructured":"Stone TW, Perkins MN (1981) Quinolinic acid: a potent endogenous excitant at amino acid receptors in the CNS. Eur J Pharmacol 72:411\u2013412","journal-title":"Eur J Pharmacol"},{"key":"676_CR111","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0301-0082(00)00032-0","volume":"64","author":"TW Stone","year":"2001","unstructured":"Stone TW (2001) Kynurenines in the CNS\u2014from obscurity to therapeutic importance. Prog Neurobiol 64:185\u2013218","journal-title":"Prog Neurobiol"},{"key":"676_CR112","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1111\/j.1460-9568.2007.05540.x","volume":"25","author":"TW Stone","year":"2007","unstructured":"Stone TW (2007) Kynurenic acid blocks nicotinic synaptic transmission to hippocampal interneurons in young rats. Eur J Neurosci 25:2656\u20132665","journal-title":"Eur J Neurosci"},{"key":"676_CR113","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1097\/00001756-199406020-00026","volume":"5","author":"E Storey","year":"1994","unstructured":"Storey E, Cipolloni PB, Ferrrante RJ, Kowall NW, Beal MF (1994) Movement disorder following excitotoxin lesions in primates. Neuroreport 5:1259\u20131261","journal-title":"Neuroreport"},{"key":"676_CR114","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1471-4159.2005.03070.x","volume":"93","author":"N Stoy","year":"2005","unstructured":"Stoy N, Mackay GM, Forrest CM, Christofides J, Egerton M, Stone TW, Darlington LG (2005) Tryptophan metabolism and oxidative stress in patients with Huntington\u2019s disease. J Neurochem 93:611\u2013623","journal-title":"J Neurochem"},{"key":"676_CR115","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/1531-8249(200001)47:1<80::AID-ANA13>3.0.CO;2-K","volume":"47","author":"SJ Tabrizi","year":"2000","unstructured":"Tabrizi SJ, Workman J, Hart PE, Mangiarini L, Mahal A, Bates G, Cooper JM, Schapira AHV (2000) Mitochondrial dysfunction and free radical damage in the Huntington R6\/2 transgenic mouse. Ann Neurol 47:80\u201386","journal-title":"Ann Neurol"},{"key":"676_CR116","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1097\/00001756-199505300-00013","volume":"6","author":"SB Tatter","year":"1995","unstructured":"Tatter SB, Galpern WR, Hoogeveen AT, Isacson O (1995) Effects of striatal excitotoxicity on Huntington-like immunoreactivity. Neuroreport 6:1125\u20131129","journal-title":"Neuroreport"},{"key":"676_CR117","doi-asserted-by":"crossref","unstructured":"Tauber E, Miller-Fleming L, Mason RP, Kwan W, Clapp J, Butler NJ, Outeiro TF, Muchowski PJ, Giorgini F (2010) Functional gene expression profiling in yeast implicates translational dysfunction in mutant huntingtin toxicity. J Biol Chem (in press)","DOI":"10.1074\/jbc.M110.101527"},{"key":"676_CR118","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1084\/jem.20020052","volume":"196","author":"P Terness","year":"2002","unstructured":"Terness P, Bauer TM, Rose L, Dufter C, Watzlik A, Simon H, Opelz G (2002) Inhibition of allogeneic T cell proliferation by indoleamine 2, 3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites. J Exp Med 196:447\u2013457","journal-title":"J Exp Med"},{"key":"676_CR119","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nsmb.1570","volume":"16","author":"AK Thakur","year":"2009","unstructured":"Thakur AK, Jayaraman M, Mishra R, Thakur M, Chellgren VM, Byeon IJ et al (2009) Polyglutamine disruption of the huntingtin exon 1\u00a0N terminus triggers a complex aggregation mechanism. Nat Struct Mol Biol 16:380\u2013389","journal-title":"Nat Struct Mol Biol"},{"key":"676_CR120","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/mds.870110204","volume":"11","author":"The Huntington Study Group","year":"1996","unstructured":"The Huntington Study Group (1996) Unified Huntington\u2019s disease rating scale: reliability and consistency. Mov Disord 11:136\u2013142","journal-title":"Mov Disord"},{"key":"676_CR121","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1179\/135100099101534927","volume":"4","author":"SR Thomas","year":"1999","unstructured":"Thomas SR, Stocker R (1999) Redox reactions related to indoleamine 2, 3-dioxygenase and tryptophan metabolism along the kynurenine pathway. Redox Rep 4:199\u2013220","journal-title":"Redox Rep"},{"key":"676_CR122","doi-asserted-by":"crossref","first-page":"32714","DOI":"10.1074\/jbc.271.51.32714","volume":"271","author":"SR Thomas","year":"1996","unstructured":"Thomas SR, Witting PK, Stocker R (1996) 3-Hydroxyanthranilic acid is an efficient, cell-derived co-antioxidant for alpha-tocopherol, inhibiting human low density lipoprotein and plasma lipid peroxidation. J Biol Chem 271:32714\u201332721","journal-title":"J Biol Chem"},{"key":"676_CR123","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1093\/hmg\/8.5.839","volume":"8","author":"MT Usdin","year":"1999","unstructured":"Usdin MT, Shelbourne PF, Myers RM, Madison DV (1999) Impaired synaptic plasticity in mice carrying the Huntington\u2019s disease mutation. Human Mol Genet 8:839\u2013846","journal-title":"Human Mol Genet"},{"key":"676_CR124","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/0091-3057(91)90211-J","volume":"39","author":"L Vecsei","year":"1991","unstructured":"Vecsei L, Beal MF (1991) Comparative behavioral and neurochemical studies with striatal kainic acid-lesioned or quinolinic acid-lesioned rats. Pharmacol Biochem Behav 39:473\u2013478","journal-title":"Pharmacol Biochem Behav"},{"key":"676_CR125","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.cnr.2006.09.008","volume":"6","author":"ZS Vexler","year":"2006","unstructured":"Vexler ZS, Tang XN, Yenari MA (2006) Inflammation in adult and neonatal stroke. Clin Neurosci Res 6:293\u2013313","journal-title":"Clin Neurosci Res"},{"key":"676_CR126","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/eji.200535616","volume":"36","author":"WP Weber","year":"2006","unstructured":"Weber WP, Feder-Mengus C, Chiarugi A, Rosenthal R, Reschner A, Schumacher R, Zajaz P, Misteli H, Frey DM, Oertli D, Heberer M, Spagnoli GC (2006) Differential effects of the tryptophan metabolite 3-hydroxyanthranilic acid on the proliferation of human CD8(+) T cells induced by TCR triggering or homeostatic cytokines. Eur J Immunol 36:296\u2013304","journal-title":"Eur J Immunol"},{"key":"676_CR127","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1515\/pteridines.2002.13.4.140","volume":"13","author":"G Weiss","year":"2002","unstructured":"Weiss G, Diez-Ruiz A, Murr C, Theurl I, Fuchs D (2002) Tryptophan metabolites as scavengers of reactive oxygen and chlorine species. Pteridines 13:140\u2013144","journal-title":"Pteridines"},{"key":"676_CR128","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0024-3205(87)90149-4","volume":"41","author":"ER Werner","year":"1987","unstructured":"Werner ER, Bitterlich G, Fuchs D, Hausen A, Reibnegger G, Szabo G (1987) Human macrophages degrade tryptophan upon induction by interferon-\u03b3. Life Sci 41:273\u2013280","journal-title":"Life Sci"},{"key":"676_CR129","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1042\/bj2620861","volume":"262","author":"ER Werner","year":"1989","unstructured":"Werner ER, Werner-Felmayer G, Fuchs D, Hausen A, Reibnegger G, Wachter H (1989) Parallel induction of tetrahydrobiopterin biosynthesis and indoleamine 2, 3-dioxygenase activity in human cells and cell lines by interferon-gamma. Biochem J 262:861\u2013866","journal-title":"Biochem J"},{"key":"676_CR130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-510X(00)00386-5","volume":"179","author":"BC White","year":"2000","unstructured":"White BC, Sullivan JM, De Gracia DJ, O\u2019Neill BJ, Neumar RW, Grossman LI, Rafols JA, Krause GS (2000) Brain ischemia and reperfusion: molecular mechanisms of neuronal injury. J Neurol Sci 179:1\u201333","journal-title":"J Neurol Sci"},{"key":"676_CR131","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2174\/1389200003339063","volume":"1","author":"B Widner","year":"2000","unstructured":"Widner B, Ledochowski M, Fuchs D (2000) Interferon-gamma-induced tryptophan degradation: neuropsychiatric and immunological consequences. Curr Drug Metabol 1:193\u2013204","journal-title":"Curr Drug Metabol"},{"key":"676_CR132","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1093\/brain\/awh609","volume":"128","author":"H Wiendl","year":"2005","unstructured":"Wiendl H, Feger U, Mittelbronn M, Jack C, Schreiner B, Stadelmann C et al (2005) Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity. Brain 128:2689\u20132704","journal-title":"Brain"},{"key":"676_CR133","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.humimm.2006.10.021","volume":"68","author":"H Wiendl","year":"2007","unstructured":"Wiendl H (2007) HLA-G in the nervous system. Human Immunol 68:286\u2013293","journal-title":"Human Immunol"},{"key":"676_CR134","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.2174\/0929867033457179","volume":"10","author":"B Wirleitner","year":"2003","unstructured":"Wirleitner B, Neurauter G, Schrocksnadel K, Frick B, Fuchs D (2003a) Interferon-gamma-induced conversion of tryptophan: immunologic and neuropsychiatric aspects. Curr Med Chem 10:1581\u20131591","journal-title":"Curr Med Chem"},{"key":"676_CR135","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1046\/j.1365-2362.2003.01186.x","volume":"33","author":"B Wirleitner","year":"2003","unstructured":"Wirleitner B, Rudzite V, Neurauter G, Murr C, Kalnins U, Erglis A, Trusinskis K, Fuchs D (2003b) Immune activation and degradation of tryptophan in coronary heart disease. Eur J Clin Invest 33:550\u2013554","journal-title":"Eur J Clin Invest"},{"key":"676_CR136","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.imlet.2008.08.008","volume":"121","author":"H Xu","year":"2008","unstructured":"Xu H, Zhang GX, Ciric B, Rostami A (2008) IDO: a double-edged sword for T(H)1\/T(H)2 regulation. Immunol Lett 121:1\u20136","journal-title":"Immunol Lett"},{"key":"676_CR137","doi-asserted-by":"crossref","first-page":"5953","DOI":"10.4049\/jimmunol.1001628","volume":"185","author":"Y Yan","year":"2010","unstructured":"Yan Y, Zhang GX, Gran B, Fallarino F, Yu S, Li H, Cullimore ML, Roatami A, Xu H (2010) IDO upregulates regulatory T cells via tryptophan catabolite and suppresses encephalitogenic T cell responses in experimental autoimmune encephalomyelitis. J Immunol 185:5953\u20135961","journal-title":"J Immunol"},{"key":"676_CR138","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1073\/pnas.0408936102","volume":"102","author":"XQ Zhang","year":"2005","unstructured":"Zhang XQ, Smith DL, Merlin AB, Engemann S, Russel DE, Roark M et al (2005) A potent small molecule inhibits polyglutamine aggregation in Huntington\u2019s disease neurons and suppresses neurodegeneration in vivo. Proc Natl Acad Sci USA 102:892\u2013897","journal-title":"Proc Natl Acad Sci USA"},{"key":"676_CR139","first-page":"831","volume":"25","author":"BT Zhu","year":"2010","unstructured":"Zhu BT (2010) Development of selective immune tolerance towards the allogeneic fetus during pregnancy: role of tryptophan catabolites. Int J Mol Med 25:831\u2013835","journal-title":"Int J Mol Med"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-011-0676-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00702-011-0676-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-011-0676-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T12:29:42Z","timestamp":1741264182000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00702-011-0676-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6,22]]},"references-count":140,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["676"],"URL":"https:\/\/doi.org\/10.1007\/s00702-011-0676-8","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6,22]]}}}